Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory of Medical Genetics, |
RCV002287274 | SCV002577517 | uncertain significance | Hereditary cryohydrocytosis with reduced stomatin | 2022-07-04 | criteria provided, single submitter | clinical testing | PM2, PP2, PP3 |
Ambry Genetics | RCV003097719 | SCV003533775 | uncertain significance | Inborn genetic diseases | 2022-10-27 | criteria provided, single submitter | clinical testing | The c.250G>A (p.G84S) alteration is located in exon 3 (coding exon 3) of the SLC2A1 gene. This alteration results from a G to A substitution at nucleotide position 250, causing the glycine (G) at amino acid position 84 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Revvity Omics, |
RCV003138154 | SCV003825653 | uncertain significance | not provided | 2021-07-22 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV003445162 | SCV004173577 | uncertain significance | Epilepsy, idiopathic generalized, susceptibility to, 12 | 2023-04-11 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV003445161 | SCV004173579 | uncertain significance | Dystonia 9 | 2023-04-11 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV003445159 | SCV004173580 | uncertain significance | Encephalopathy due to GLUT1 deficiency | 2023-04-11 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV003445160 | SCV004173581 | uncertain significance | Childhood onset GLUT1 deficiency syndrome 2 | 2023-04-11 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV002287274 | SCV004173582 | uncertain significance | Hereditary cryohydrocytosis with reduced stomatin | 2023-04-11 | criteria provided, single submitter | clinical testing |